[go: up one dir, main page]

GR3019328T3 - Vampire bat salivary Plasminogen activator vPA-alpha 1 - Google Patents

Vampire bat salivary Plasminogen activator vPA-alpha 1

Info

Publication number
GR3019328T3
GR3019328T3 GR960400715T GR960400715T GR3019328T3 GR 3019328 T3 GR3019328 T3 GR 3019328T3 GR 960400715 T GR960400715 T GR 960400715T GR 960400715 T GR960400715 T GR 960400715T GR 3019328 T3 GR3019328 T3 GR 3019328T3
Authority
GR
Greece
Prior art keywords
vpa
alpha
plasminogen activator
vampire bat
salivary plasminogen
Prior art date
Application number
GR960400715T
Other languages
English (en)
Inventor
Berthold Baldus
Peter Donner
Wolf-Dieter Schleuning
Alejandro Alagon
Werner Boidol
Joern Reiner Kraetzschmar
Bernhard Jacques Haendler
Gernot Langer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3904580A external-priority patent/DE3904580A1/de
Priority claimed from DE19893917949 external-priority patent/DE3917949A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of GR3019328T3 publication Critical patent/GR3019328T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
GR960400715T 1989-02-13 1996-03-15 Vampire bat salivary Plasminogen activator vPA-alpha 1 GR3019328T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3904580A DE3904580A1 (de) 1989-02-13 1989-02-13 Neues thrombolytikum
DE19893917949 DE3917949A1 (de) 1989-05-30 1989-05-30 Neues thrombolytikum

Publications (1)

Publication Number Publication Date
GR3019328T3 true GR3019328T3 (en) 1996-06-30

Family

ID=25877826

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400715T GR3019328T3 (en) 1989-02-13 1996-03-15 Vampire bat salivary Plasminogen activator vPA-alpha 1

Country Status (16)

Country Link
EP (1) EP0383417B1 (el)
JP (1) JP2904918B2 (el)
AT (1) ATE132187T1 (el)
AU (1) AU642404B2 (el)
BR (1) BR9007115A (el)
CA (1) CA2046632C (el)
DE (1) DE69024382T2 (el)
DK (1) DK0383417T3 (el)
ES (1) ES2085326T3 (el)
FI (1) FI103577B1 (el)
GR (1) GR3019328T3 (el)
HU (1) HU217219B (el)
IE (1) IE73229B1 (el)
NO (1) NO308708B1 (el)
UA (1) UA34415C2 (el)
WO (1) WO1990009438A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
DE10016139A1 (de) * 2000-03-27 2001-10-18 Schleuning Wolf Dieter Verfahren zur Bestimmung von löslichem Fibrin
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
CA2522989A1 (en) * 2003-05-21 2004-12-02 Ares Trading S.A. Method of chromatographic analysis of a protein solution
DE10342518A1 (de) 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
GB0321997D0 (en) 2003-09-19 2003-10-22 Novartis Ag Organic compound
DE202006015207U1 (de) * 2006-05-19 2007-08-16 Paion Deutschland Gmbh Verwendung vn Plasminogenaktivatoren zur Behandlung einer Venenthromboembolie
US8299221B2 (en) 2006-11-17 2012-10-30 Novartis Ag LINGO binding molecules and pharmaceutical use thereof
CA2704357C (en) 2007-11-02 2016-06-21 Novartis Ag Improved nogo-a binding molecules and pharmaceutical use thereof
EP2558580A2 (en) 2010-04-16 2013-02-20 H. Lundbeck A/S Method for the manufacture of recombinant dspa alpha1
KR20220087516A (ko) 2019-10-24 2022-06-24 노바고 테라퓨틱스 아게 신규 항-Nogo-A 항체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators

Also Published As

Publication number Publication date
NO913129D0 (no) 1991-08-12
AU642404B2 (en) 1993-10-21
DE69024382T2 (de) 1996-08-14
CA2046632C (en) 1999-05-11
FI913818A0 (fi) 1991-08-12
ES2085326T3 (es) 1996-06-01
DK0383417T3 (da) 1996-05-13
HU902004D0 (en) 1991-11-28
HUT59724A (en) 1992-06-29
WO1990009438A1 (en) 1990-08-23
DE69024382D1 (de) 1996-02-08
EP0383417A1 (en) 1990-08-22
HU217219B (hu) 1999-12-28
BR9007115A (pt) 1991-11-26
FI103577B (fi) 1999-07-30
FI103577B1 (fi) 1999-07-30
ATE132187T1 (de) 1996-01-15
NO913129L (no) 1991-10-11
IE73229B1 (en) 1997-05-21
CA2046632A1 (en) 1990-08-14
JPH04504799A (ja) 1992-08-27
JP2904918B2 (ja) 1999-06-14
EP0383417B1 (en) 1995-12-27
UA34415C2 (uk) 2001-03-15
AU5080790A (en) 1990-09-05
NO308708B1 (no) 2000-10-16
IE900506L (en) 1990-08-13

Similar Documents

Publication Publication Date Title
EP0787802A3 (el)
GR3019328T3 (en) Vampire bat salivary Plasminogen activator vPA-alpha 1
GB2194748B (en) Coagulation forceps
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
DE10199044I2 (de) Varianten des Gewebeplasminogenaktivators mit verbesserter Therapeutischer wirkung
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
EP0266993A3 (en) Method and therapeutic compositions for the treatment of bleeding disorders
IT8767494A0 (it) Composizione liquida per il trattamento preventivo e curativo di malattie crittogamiche di tipo oidio e procedimento per la messa in opera di tale composizione
IT216694Z2 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
GR3005408T3 (el)
ZA868813B (en) Dna sequence,recombinant dna and process for producing human tissue plasminogen activator
FI880891A7 (fi) Humaanikudoksen plasminogeenin rekombinanttiaktivaattorin koostumus.
IE871856L (en) "modified tissue plasminogen activator"
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.
RO105585B1 (ro) Compozitie medicamentoasa folosita in tratamentul ulcerului de gamba
ZA897509B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
IL84549A0 (en) Homogeneous sheep t11ts as an intermediate for the preparation of human t11ts,and the use thereof
IL86887A0 (en) Improved human tissue plasminogen activator and its use
GB8715678D0 (en) Therapeutic lysis of fibrin blood clots
GB8707551D0 (en) Therapeutic lysis of fibrin blood clots
JPS56166848A (en) Left and right oscillation type beauty health machine doubling as human body gyroscope
IT213397Z2 (it) Contenitore per la raccolta differenziata dei residui di attivita'umana
IT1222128B (it) Procedimento per il trattamento di articolo casalinghi e articoli casalinghi trattati cosi' ottenuti